Life quality of patients with rheumatoid arthritis treated with biotherapy

Author:

Obradovic-Gajic Jelena1,Boskovic Ksenija2ORCID,Zvekic-Svorcan Jelena2ORCID,Igic Natasa1ORCID

Affiliation:

1. University of Novi Sad, Faculty of Medicine, Novi Sad

2. University of Novi Sad, Faculty of Medicine, Novi Sad + Special Hospital for Rheumatic Diseases, Novi Sad

Abstract

Introduction. Rheumatoid arthritis is a chronic disease that causes joint damage and loss of function, thus impairing quality of life. Administration of biological drugs can change the course of the disease and improve life quality and functional capacity of patients. The objective of the study is to examine the quality of life in patients with rheumatoid arthritis treated with biological therapy. Material and Methods. The prospective cross-sectional study followed 56 patients of both sexes treated with biological drugs at the Special Hospital for Rheumatic Diseases, Novi Sad. The data were collected using a standardized questionnaire for monitoring the quality of life (Health Assessment Questionnaire-disability index) and a general questionnaire, containing socio-demographic data, disease and therapy data. Computer program Statistical Package for the Social Sciences version 24 was used for data processing. Results. The results of the assessment of the life quality of patients with rheumatoid arthritis undergoing biological therapy showed that the values of the Health Assessment Questionnaire-disability index range from Min=0.00 to Max=2.25, with the mean M=0.76. Observed by category, 39.3% of participants are in remission, while the rest (60.7%) have low disease activity. The Health Assessment Questionnaire-disability index has a statistically significant correlation with the place of residence (p<0.05), as well as with the duration of morning stiffness (p<0.01). The Health Assessment Questionnaire-disability index has no statistically significant correlation with other general data, disease and therapy data. Conclusion. Applica?tion of biotherapy on patients with rheumatoid arthritis leads to low disease activity and remission, which results in good quality of life.

Publisher

National Library of Serbia

Reference31 articles.

1. Bošković K, Gojković Z, Jović M, Jovićević P, Janković T, Zvekić-Svorcan J. Health concerns of patients with rheumatoid arthritis during the coronavirus disease 2019 pandemic. Med Pregl. 2021;74(9-10):291-7.

2. Mileta A. Učinkovitost i sigurnost bioloških DMARD i ciljanih sintetskih DMARD lijekova u bolesnika s upalnim reumatskim bolestima [thesis]. Osijek: Sveučilište Josipa Jurja Strossmayera u Osijeku, Medicinski fakultet; 2020.

3. Majnik J, Császár-Nagy N, Böcskei G, Bender T, Nagy G. Non-pharmacological treatment in difficult-to-treat rheumatoid arthritis. Front Med (Lausanne). 2022;9:991677.

4. Golubović S. Uticaj različitih terapijskih modaliteta, citokina i aktivnosti bolesti na bihevioralni status bolesnika sa reumatoidnim artritisom [dissertation]. Novi Sad: Univerzitet u Novom Sadu, Medicinski fakultet; 2022.

5. Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018;6(1):15.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3